Introduction: The aim of the study was to analyze the published evidence for the use of fallopian tube brush cytology for the early detection of extrauterine serous gynecological cancer. Methods: We systematically searched the literature and, additionally, cross-checked on the bibliographies of selected articles. The inclusion criteria involved studies assessing the utility of fallopian tube brush cytology and its applications in the diagnosis, screening, or follow-up of extrauterine serous gynecological cancer. Results: The search strategy resulted in 21 abstracts or full-text articles, 5 of which met the inclusion criteria. The year of publication ranged from 2016 to 2022, and a total of 193 fallopian tube samples were investigated. Cytobrush, Tubebrush©, and Cytuity™ were used to obtain salpingeal samples for liquid-based cytology evaluation. Conclusions: Our findings indicate that, at present, there is a lack of satisfying evidence-based data in the literature which would support the implementation of fallopian tube brush cytology as an adjunctive tool for early detection of extrauterine serous gynecological cancer. Thus, we believe that there is need for well-designed clinical studies to assess the effectiveness and diagnostic accuracy of the method as well as to validate the cytological criteria for the diagnosis and prediction of gynecological malignancies.

Keywords:
Adnexal malignancy, Carcinoma, Fallopian tube cytology, Gynecologic cytology, Ovarian cancer
1.
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021 Jan;71(1):7–33.
https://doi.org/10.3322/caac.21654
2.
Berek JS, Renz M, Kehoe S, Kumar L, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. Int J Gynaecol Obstet. 2021 Oct;155(Suppl 1):61–85.
3.
Cianci A, Palumbo G, Tempera G, Furneri PM. C. trachomatis detection in infertile women by using a tubal cytobrush during laparoscopy. Acta Eur Fertil. 1989 Nov-Dec;20(6):363–5.
4.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
https://doi.org/10.1371/journal.pmed.1000100
5.
Dudkiewicz J. Cytomorphology of epithelial cells of Fallopian tubes obtained by aspiration from operative specimens. Am J Obstet Gynecol. 1968 Sep 1;102(1):82–90.
https://doi.org/10.1016/0002-9378(68)90436-5
6.
Mulvany NJ, Arnstein M, Ostör AG. Fallopian tube cytology: a histocorrelative study of 150 washings. Diagn Cytopathol. 1997 Jun;16(6):483–8.
7.
Haeusler G, Tempfer C, Lehner R, Sam C, Kainz C. Fallopian tissue sampling with a cytobrush during hysteroscopy: a new approach for detecting tubal infection. Fertil Steril. 1997 Mar;67(3):580–2.
8.
Matsushima T, Kaseki H, Ishihara K, Araki T. Assessment of fallopian tube cytology for the diagnosis of endometriosis and hydrosalpinx. J Nippon Med Sch. 2002 Oct;69(5):445–50.
9.
Aali BS, Malekpour R, Nakheii N, Mehdizadeh A. Utility and diagnostic accuracy of fallopian tube touch imprint cytology. Cytopathology. 2005 Oct;16(5):252–5.
10.
Lum D, Guido R, Rodriguez E, Lee T, Mansuria S, D’Ambrosio L, et al. Brush cytology of the fallopian tube and implications in ovarian cancer screening. J Minim Invasive Gynecol. 2014 Sep-Oct;21(5):851–6.
https://doi.org/10.1016/j.jmig.2014.03.017
11.
Rodriguez EF, Lum D, Guido R, Austin RM. Cytologic findings in experimental in vivo fallopian tube brush specimens. Acta Cytol. 2013;57(6):611–8.
https://doi.org/10.1159/000353825
12.
Gordts S, Campo R, Bogers JP, Tanos V, Segaert I, Valkenburg M, et al. Transvaginal laparoscopy: a minimally invasive approach to obtain brush cytology of the Fallopian tube. Eur J Obstet Gynecol Reprod Biol. 2017 May;212:80–4.
https://doi.org/10.1016/j.ejogrb.2017.03.002
13.
Chen H, Klein R, Arnold S, Chambers S, Zheng W. Cytologic studies of the fallopian tube in patients undergoing salpingo-oophorectomy. Cancer Cell Int. 2016 Oct 1;16:78.
14.
Dhanani M, Nassar A, Charles MS, Dinh T. Cytology of the fallopian tube: a screening model for high-grade serous carcinoma. CytoJournal. 2018 Nov 12;15:28.
15.
Chui MH, Vang R, Wang TL, Shih IM, VandenBussche CJ. Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma. Cancer Cytopathol. 2019 Mar;127(3):192–201.
16.
Powell CB, Littell RD, Landen CNJr, Pramanik S, Hamilton IC, Suh-Burgmann EJ. Cytological sampling of fallopian tubes using a hysteroscopic catheter: a multi-center study. Gynecol Oncol. 2020 Mar;156(3):636–40.
https://doi.org/10.1016/j.ygyno.2019.12.026
17.
Lekka S, Psomiadou V, Panoskaltsis T, Tsouma E, Novkovic N, Trihia H, et al. CytoSaLPs score: a promising new tool for the detection and screening of extrauterine high grade serous carcinoma. BMC Cancer. 2023 Feb 16;23(1):157.
18.
Gibb RK, Martens MG. The impact of liquid-based cytology in decreasing the incidence of cervical cancer. Rev Obstet Gynecol. 2011;4(Suppl 1):S2–11.
19.
Clarke-Pearson DL. Screening for ovarian cancer. N Engl J Med. 2009 Jul 9;361(2):170–7.
© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.